FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

2.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

3.

Glioblastoma treatment breakthrough shows promise

4.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

5.

FDA Approves New Drug Combo for RR Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot